| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K36me/H3K36me2 demethylase activity | 3.38e-05 | 4 | 48 | 2 | GO:0140680 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.63e-05 | 5 | 48 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 3.07e-04 | 11 | 48 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 3.68e-04 | 12 | 48 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 5.06e-04 | 14 | 48 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.05e-03 | 875 | 48 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.91e-03 | 27 | 48 | 2 | GO:0004709 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.06e-03 | 28 | 48 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.52e-03 | 31 | 48 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 2.52e-03 | 31 | 48 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.68e-03 | 32 | 48 | 2 | GO:0140457 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.28e-06 | 48 | 47 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.28e-06 | 48 | 47 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.66e-05 | 22 | 47 | 3 | GO:1902514 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 1.90e-05 | 23 | 47 | 3 | GO:0061577 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 5.06e-05 | 5 | 47 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.31e-05 | 98 | 47 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.84e-04 | 233 | 47 | 5 | GO:0061351 | |
| GeneOntologyBiologicalProcess | protein demethylation | 2.26e-04 | 10 | 47 | 2 | GO:0006482 | |
| GeneOntologyBiologicalProcess | protein dealkylation | 2.26e-04 | 10 | 47 | 2 | GO:0008214 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.05e-04 | 142 | 47 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.05e-04 | 142 | 47 | 4 | GO:0098659 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 3.08e-04 | 12 | 46 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.57e-04 | 73 | 46 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | NuRD complex | 6.31e-04 | 17 | 46 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 6.31e-04 | 17 | 46 | 2 | GO:0090545 | |
| Domain | CHDCT2 | 1.70e-05 | 3 | 45 | 2 | PF08074 | |
| Domain | CHDNT | 1.70e-05 | 3 | 45 | 2 | PF08073 | |
| Domain | DUF1086 | 1.70e-05 | 3 | 45 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.70e-05 | 3 | 45 | 2 | IPR009463 | |
| Domain | CHD_N | 1.70e-05 | 3 | 45 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.70e-05 | 3 | 45 | 2 | IPR012957 | |
| Domain | CAC1F_C | 1.70e-05 | 3 | 45 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.70e-05 | 3 | 45 | 2 | PF16885 | |
| Domain | DUF1087 | 1.70e-05 | 3 | 45 | 2 | PF06465 | |
| Domain | DUF1086 | 1.70e-05 | 3 | 45 | 2 | PF06461 | |
| Domain | DUF1087 | 1.70e-05 | 3 | 45 | 2 | SM01147 | |
| Domain | DUF1086 | 1.70e-05 | 3 | 45 | 2 | SM01146 | |
| Domain | MLK1/MLK2/MLK4 | 3.40e-05 | 4 | 45 | 2 | IPR016231 | |
| Domain | VDCC_L_a1su | 3.40e-05 | 4 | 45 | 2 | IPR005446 | |
| Domain | MAP3K10 | 3.40e-05 | 4 | 45 | 2 | IPR015785 | |
| Domain | Znf_PHD-finger | 3.87e-05 | 79 | 45 | 4 | IPR019787 | |
| Domain | PHD | 6.18e-05 | 89 | 45 | 4 | SM00249 | |
| Domain | Znf_PHD | 6.74e-05 | 91 | 45 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 7.98e-05 | 95 | 45 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 8.31e-05 | 96 | 45 | 4 | PS01359 | |
| Domain | VDCC_a1su_IQ | 1.18e-04 | 7 | 45 | 2 | IPR014873 | |
| Domain | GPHH | 1.18e-04 | 7 | 45 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.18e-04 | 7 | 45 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.18e-04 | 7 | 45 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.18e-04 | 7 | 45 | 2 | PF08763 | |
| Domain | VDCCAlpha1 | 2.52e-04 | 10 | 45 | 2 | IPR002077 | |
| Domain | Znf_FYVE_PHD | 4.27e-04 | 147 | 45 | 4 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 5.14e-04 | 65 | 45 | 3 | IPR019786 | |
| Domain | EF-hand-dom_pair | 6.11e-04 | 287 | 45 | 5 | IPR011992 | |
| Domain | PHD | 7.82e-04 | 75 | 45 | 3 | PF00628 | |
| Domain | Chromo_domain | 1.51e-03 | 24 | 45 | 2 | IPR023780 | |
| Domain | JmjC | 1.51e-03 | 24 | 45 | 2 | PF02373 | |
| Domain | Ser/Thr_kinase_AS | 1.62e-03 | 357 | 45 | 5 | IPR008271 | |
| Domain | S_TKc | 1.66e-03 | 359 | 45 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.72e-03 | 362 | 45 | 5 | PS00108 | |
| Domain | Chromo | 1.78e-03 | 26 | 45 | 2 | PF00385 | |
| Domain | CHROMO_1 | 2.06e-03 | 28 | 45 | 2 | PS00598 | |
| Domain | S100/CaBP-9k_CS | 2.06e-03 | 28 | 45 | 2 | IPR001751 | |
| Domain | CHROMO_2 | 2.06e-03 | 28 | 45 | 2 | PS50013 | |
| Domain | Protein_kinase_ATP_BS | 2.10e-03 | 379 | 45 | 5 | IPR017441 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | IPR000330 | |
| Domain | JMJC | 2.69e-03 | 32 | 45 | 2 | PS51184 | |
| Domain | Chromodomain-like | 2.69e-03 | 32 | 45 | 2 | IPR016197 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | PF00176 | |
| Domain | JmjC_dom | 2.69e-03 | 32 | 45 | 2 | IPR003347 | |
| Domain | JmjC | 2.86e-03 | 33 | 45 | 2 | SM00558 | |
| Domain | Chromo/shadow_dom | 2.86e-03 | 33 | 45 | 2 | IPR000953 | |
| Domain | CHROMO | 2.86e-03 | 33 | 45 | 2 | SM00298 | |
| Domain | RGS | 3.21e-03 | 35 | 45 | 2 | PF00615 | |
| Domain | RGS | 3.21e-03 | 35 | 45 | 2 | SM00315 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.21e-03 | 35 | 45 | 2 | IPR002464 | |
| Domain | RGS | 3.39e-03 | 36 | 45 | 2 | PS50132 | |
| Domain | DEAH_ATP_HELICASE | 3.78e-03 | 38 | 45 | 2 | PS00690 | |
| Domain | RGS | 3.97e-03 | 39 | 45 | 2 | IPR016137 | |
| Domain | - | 4.35e-03 | 449 | 45 | 5 | 3.30.40.10 | |
| Domain | PROTEIN_KINASE_ATP | 4.77e-03 | 459 | 45 | 5 | PS00107 | |
| Domain | Znf_RING/FYVE/PHD | 4.77e-03 | 459 | 45 | 5 | IPR013083 | |
| Domain | Prot_kinase_dom | 6.22e-03 | 489 | 45 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 6.43e-03 | 493 | 45 | 5 | PS50011 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.98e-05 | 6 | 31 | 2 | M47762 | |
| Pathway | WP_MAPK_SIGNALING | 1.82e-04 | 246 | 31 | 5 | M39597 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.66e-04 | 267 | 31 | 5 | M10792 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 3.05e-04 | 12 | 31 | 2 | M47929 | |
| Pathway | WP_INSULIN_SIGNALING | 3.96e-04 | 160 | 31 | 4 | M39482 | |
| Pathway | WP_INSULIN_SIGNALING | 3.96e-04 | 160 | 31 | 4 | MM15956 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 4.19e-04 | 14 | 31 | 2 | M47692 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 4.55e-04 | 166 | 31 | 4 | M16024 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.62e-04 | 74 | 31 | 3 | MM15962 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24849370 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20014384 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 1.87e-06 | 2 | 48 | 2 | 26049024 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17015854 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30001160 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 1.87e-06 | 2 | 48 | 2 | 16706838 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23761887 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 14981074 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21352396 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 1.87e-06 | 2 | 48 | 2 | 25292336 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17526649 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 1.87e-06 | 2 | 48 | 2 | 24941892 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 1.87e-06 | 2 | 48 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 1.87e-06 | 2 | 48 | 2 | 16267232 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24848473 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22826131 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24996399 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24470632 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24760982 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24086669 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 5.59e-06 | 3 | 48 | 2 | 21832054 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17289261 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 5.59e-06 | 3 | 48 | 2 | 23973784 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 26831068 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17767505 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 31302118 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23045342 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23338940 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 2173707 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 5.59e-06 | 3 | 48 | 2 | 24934288 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 ANKRD11 KDM2B CHD4 DNAJC1 RPL7L1 PHF8 UBN1 GTF3C1 ATAD5 | 8.84e-06 | 1294 | 48 | 10 | 30804502 |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 20937870 | ||
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 1.12e-05 | 4 | 48 | 2 | 17110593 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 31663850 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 11296258 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 15451373 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.91e-05 | 608 | 48 | 7 | 36089195 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.14e-05 | 861 | 48 | 8 | 36931259 | |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 2.79e-05 | 6 | 48 | 2 | 16029198 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 21224388 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23734214 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 20639889 | ||
| Pubmed | 3.10e-05 | 129 | 48 | 4 | 23022380 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 21057379 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 12900400 | ||
| Pubmed | 5.70e-05 | 1285 | 48 | 9 | 35914814 | ||
| Pubmed | Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation. | 6.67e-05 | 9 | 48 | 2 | 21245044 | |
| Pubmed | 6.85e-05 | 57 | 48 | 3 | 21555454 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 7.75e-05 | 759 | 48 | 7 | 35915203 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.76e-05 | 774 | 48 | 7 | 15302935 | |
| Pubmed | 9.41e-05 | 332 | 48 | 5 | 37433992 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 18809727 | ||
| Pubmed | 1.04e-04 | 339 | 48 | 5 | 30415952 | ||
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 1.06e-04 | 66 | 48 | 3 | 24811749 | |
| Pubmed | 1.18e-04 | 182 | 48 | 4 | 15102471 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.24e-04 | 1105 | 48 | 8 | 35748872 | |
| Pubmed | 1.28e-04 | 1429 | 48 | 9 | 35140242 | ||
| Pubmed | 1.32e-04 | 1116 | 48 | 8 | 31753913 | ||
| Pubmed | 1.82e-04 | 1497 | 48 | 9 | 31527615 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 20188150 | ||
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 1.94e-04 | 15 | 48 | 2 | 35695185 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 24453333 | ||
| Pubmed | The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1. | 1.94e-04 | 15 | 48 | 2 | 25247294 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 12787792 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.37e-04 | 910 | 48 | 7 | 36736316 | |
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 2.50e-04 | 17 | 48 | 2 | 27725084 | |
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 27806305 | ||
| Pubmed | 2.81e-04 | 1247 | 48 | 8 | 27684187 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 19531499 | ||
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 31959764 | ||
| Pubmed | 3.85e-04 | 21 | 48 | 2 | 21703454 | ||
| Pubmed | 5.30e-04 | 483 | 48 | 5 | 36912080 | ||
| Pubmed | 5.45e-04 | 486 | 48 | 5 | 20936779 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.03e-04 | 497 | 48 | 5 | 36774506 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.14e-04 | 281 | 48 | 4 | 28706196 | |
| Pubmed | Excess neuropeptides in lung signal through endothelial cells to impair gas exchange. | 6.40e-04 | 27 | 48 | 2 | 35303432 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 6.40e-04 | 27 | 48 | 2 | 21791528 | |
| Pubmed | 7.30e-04 | 1440 | 48 | 8 | 30833792 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 24105743 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 7789972 | ||
| Pubmed | 8.25e-04 | 533 | 48 | 5 | 25544563 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 8.25e-04 | 533 | 48 | 5 | 30554943 | |
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 8.45e-04 | 31 | 48 | 2 | 23602572 | |
| Pubmed | 9.01e-04 | 32 | 48 | 2 | 19285159 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 9.07e-04 | 1489 | 48 | 8 | 28611215 | |
| Pubmed | 9.26e-04 | 547 | 48 | 5 | 37267103 | ||
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 9.58e-04 | 33 | 48 | 2 | 15755804 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 9.58e-04 | 33 | 48 | 2 | 22357600 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 9.58e-04 | 33 | 48 | 2 | 26864203 | |
| Pubmed | 9.58e-04 | 33 | 48 | 2 | 18271526 | ||
| Pubmed | 1.05e-03 | 1168 | 48 | 7 | 19946888 | ||
| Pubmed | Identification of the BRD1 interaction network and its impact on mental disorder risk. | 1.08e-03 | 35 | 48 | 2 | 27142060 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.11e-03 | 147 | 48 | 3 | 28977470 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 1.14e-03 | 36 | 48 | 2 | 29089422 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.27e-03 | 38 | 48 | 2 | 30786075 | |
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 33283408 | ||
| Interaction | NOP56 interactions | USP36 ANKRD11 CHD4 OPTN PHF8 HECTD1 ARHGAP36 CIT ATAD5 PRRC2A | 7.52e-07 | 570 | 48 | 10 | int:NOP56 |
| Interaction | POLR1G interactions | 1.96e-06 | 489 | 48 | 9 | int:POLR1G | |
| Interaction | ADAR interactions | 4.82e-06 | 286 | 48 | 7 | int:ADAR | |
| Interaction | NIFK interactions | 7.31e-06 | 431 | 48 | 8 | int:NIFK | |
| Interaction | RPL4 interactions | USP36 ANKRD11 CHD4 DNAJC1 RPL7L1 GTF3C1 HECTD1 CIT PRRC2A BAG1 | 1.02e-05 | 764 | 48 | 10 | int:RPL4 |
| Interaction | H2BC12 interactions | 1.05e-05 | 322 | 48 | 7 | int:H2BC12 | |
| Interaction | KPNA2 interactions | 2.79e-05 | 519 | 48 | 8 | int:KPNA2 | |
| Interaction | PUM3 interactions | 2.98e-05 | 254 | 48 | 6 | int:PUM3 | |
| Interaction | WDR12 interactions | 4.09e-05 | 162 | 48 | 5 | int:WDR12 | |
| Interaction | COIL interactions | 4.33e-05 | 552 | 48 | 8 | int:COIL | |
| Interaction | RPL12 interactions | 4.34e-05 | 402 | 48 | 7 | int:RPL12 | |
| Interaction | GTF3C2 interactions | 5.00e-05 | 169 | 48 | 5 | int:GTF3C2 | |
| Interaction | EIF4A2 interactions | 5.29e-05 | 171 | 48 | 5 | int:EIF4A2 | |
| Interaction | RBM15 interactions | 5.90e-05 | 175 | 48 | 5 | int:RBM15 | |
| Interaction | RPL27 interactions | 6.73e-05 | 431 | 48 | 7 | int:RPL27 | |
| Interaction | EXOSC2 interactions | 6.74e-05 | 180 | 48 | 5 | int:EXOSC2 | |
| Interaction | DNAJC9 interactions | 6.97e-05 | 296 | 48 | 6 | int:DNAJC9 | |
| Interaction | ZNF330 interactions | 8.34e-05 | 446 | 48 | 7 | int:ZNF330 | |
| Interaction | BOP1 interactions | 8.93e-05 | 191 | 48 | 5 | int:BOP1 | |
| Interaction | EXOSC3 interactions | 9.39e-05 | 100 | 48 | 4 | int:EXOSC3 | |
| Interaction | NCL interactions | 9.57e-05 | 798 | 48 | 9 | int:NCL | |
| Interaction | RRP1B interactions | 9.65e-05 | 314 | 48 | 6 | int:RRP1B | |
| Interaction | ABCF1 interactions | 1.13e-04 | 201 | 48 | 5 | int:ABCF1 | |
| Interaction | FAM228B interactions | 1.16e-04 | 7 | 48 | 2 | int:FAM228B | |
| Interaction | NOLC1 interactions | 1.17e-04 | 325 | 48 | 6 | int:NOLC1 | |
| Interaction | RPL19 interactions | 1.19e-04 | 638 | 48 | 8 | int:RPL19 | |
| Interaction | BAZ1B interactions | 1.22e-04 | 204 | 48 | 5 | int:BAZ1B | |
| Interaction | RPL30 interactions | 1.22e-04 | 474 | 48 | 7 | int:RPL30 | |
| Interaction | WDR36 interactions | 1.33e-04 | 208 | 48 | 5 | int:WDR36 | |
| Interaction | MACROH2A2 interactions | 1.42e-04 | 211 | 48 | 5 | int:MACROH2A2 | |
| Interaction | RPS2 interactions | 1.46e-04 | 657 | 48 | 8 | int:RPS2 | |
| Interaction | SSH2 interactions | 1.46e-04 | 43 | 48 | 3 | int:SSH2 | |
| Interaction | PDHB interactions | 1.54e-04 | 342 | 48 | 6 | int:PDHB | |
| Interaction | POLR1E interactions | 1.74e-04 | 350 | 48 | 6 | int:POLR1E | |
| Interaction | HMGN2 interactions | 1.81e-04 | 222 | 48 | 5 | int:HMGN2 | |
| Interaction | RPL7A interactions | 1.82e-04 | 679 | 48 | 8 | int:RPL7A | |
| Interaction | RPL31 interactions | 1.84e-04 | 680 | 48 | 8 | int:RPL31 | |
| Interaction | RIF1 interactions | 1.92e-04 | 225 | 48 | 5 | int:RIF1 | |
| Interaction | RPL21 interactions | 1.94e-04 | 357 | 48 | 6 | int:RPL21 | |
| Interaction | LOC102724159 interactions | 1.98e-04 | 9 | 48 | 2 | int:LOC102724159 | |
| Interaction | XRCC5 interactions | 2.03e-04 | 515 | 48 | 7 | int:XRCC5 | |
| Interaction | TXN interactions | 2.03e-04 | 360 | 48 | 6 | int:TXN | |
| Interaction | EIF6 interactions | 2.19e-04 | 365 | 48 | 6 | int:EIF6 | |
| Interaction | GANAB interactions | 2.29e-04 | 368 | 48 | 6 | int:GANAB | |
| Interaction | PNO1 interactions | 2.51e-04 | 129 | 48 | 4 | int:PNO1 | |
| Interaction | RPS27A interactions | 2.59e-04 | 536 | 48 | 7 | int:RPS27A | |
| Interaction | CENPA interactions | 2.60e-04 | 377 | 48 | 6 | int:CENPA | |
| Interaction | RPL8 interactions | 2.68e-04 | 539 | 48 | 7 | int:RPL8 | |
| Interaction | RPL23 interactions | 2.71e-04 | 540 | 48 | 7 | int:RPL23 | |
| Interaction | HNRNPM interactions | 2.79e-04 | 723 | 48 | 8 | int:HNRNPM | |
| Interaction | NOC3L interactions | 2.80e-04 | 244 | 48 | 5 | int:NOC3L | |
| Interaction | PHGDH interactions | 2.91e-04 | 385 | 48 | 6 | int:PHGDH | |
| Interaction | CYCS interactions | 2.96e-04 | 247 | 48 | 5 | int:CYCS | |
| Interaction | RPL9 interactions | 3.48e-04 | 398 | 48 | 6 | int:RPL9 | |
| Interaction | H3-3A interactions | 3.54e-04 | 749 | 48 | 8 | int:H3-3A | |
| Interaction | DDX50 interactions | 3.55e-04 | 257 | 48 | 5 | int:DDX50 | |
| Interaction | NOL9 interactions | 3.61e-04 | 142 | 48 | 4 | int:NOL9 | |
| Interaction | DNTTIP2 interactions | 3.81e-04 | 144 | 48 | 4 | int:DNTTIP2 | |
| Interaction | RBBP4 interactions | 3.88e-04 | 573 | 48 | 7 | int:RBBP4 | |
| Interaction | MIF interactions | 4.01e-04 | 264 | 48 | 5 | int:MIF | |
| Interaction | CD55 interactions | 4.35e-04 | 62 | 48 | 3 | int:CD55 | |
| Interaction | UTP18 interactions | 4.68e-04 | 152 | 48 | 4 | int:UTP18 | |
| Interaction | RPL5 interactions | 5.42e-04 | 606 | 48 | 7 | int:RPL5 | |
| Interaction | NOC2L interactions | 5.42e-04 | 282 | 48 | 5 | int:NOC2L | |
| Interaction | WDR3 interactions | 5.67e-04 | 160 | 48 | 4 | int:WDR3 | |
| Interaction | SNU13 interactions | 5.69e-04 | 285 | 48 | 5 | int:SNU13 | |
| Interaction | CABP1 interactions | 5.72e-04 | 15 | 48 | 2 | int:CABP1 | |
| Interaction | SCN11A interactions | 5.72e-04 | 15 | 48 | 2 | int:SCN11A | |
| Interaction | NOL10 interactions | 5.94e-04 | 162 | 48 | 4 | int:NOL10 | |
| Interaction | MAK16 interactions | 5.94e-04 | 162 | 48 | 4 | int:MAK16 | |
| Interaction | EXOSC9 interactions | 5.94e-04 | 162 | 48 | 4 | int:EXOSC9 | |
| Interaction | RBM34 interactions | 6.15e-04 | 290 | 48 | 5 | int:RBM34 | |
| Interaction | PRRC2C interactions | 6.15e-04 | 290 | 48 | 5 | int:PRRC2C | |
| Interaction | RPN1 interactions | 6.16e-04 | 814 | 48 | 8 | int:RPN1 | |
| Interaction | JAK2 interactions | 6.37e-04 | 165 | 48 | 4 | int:JAK2 | |
| Interaction | NOL7 interactions | 6.47e-04 | 71 | 48 | 3 | int:NOL7 | |
| Interaction | PIH1D2 interactions | 6.47e-04 | 71 | 48 | 3 | int:PIH1D2 | |
| Interaction | DDX41 interactions | 6.51e-04 | 166 | 48 | 4 | int:DDX41 | |
| Interaction | SPMIP5 interactions | 6.53e-04 | 16 | 48 | 2 | int:SPMIP5 | |
| Interaction | UBAP2L interactions | 6.96e-04 | 298 | 48 | 5 | int:UBAP2L | |
| Interaction | IMMT interactions | 6.96e-04 | 454 | 48 | 6 | int:IMMT | |
| Interaction | NRIP1 interactions | 7.12e-04 | 170 | 48 | 4 | int:NRIP1 | |
| Interaction | UTP4 interactions | 7.12e-04 | 170 | 48 | 4 | int:UTP4 | |
| Interaction | BRIX1 interactions | 7.17e-04 | 300 | 48 | 5 | int:BRIX1 | |
| Interaction | MACROH2A1 interactions | 7.29e-04 | 458 | 48 | 6 | int:MACROH2A1 | |
| Interaction | ATP5F1C interactions | 7.37e-04 | 459 | 48 | 6 | int:ATP5F1C | |
| Interaction | PWP2 interactions | 7.44e-04 | 172 | 48 | 4 | int:PWP2 | |
| Interaction | MTA3 interactions | 7.60e-04 | 173 | 48 | 4 | int:MTA3 | |
| Interaction | DDX56 interactions | 7.61e-04 | 304 | 48 | 5 | int:DDX56 | |
| Interaction | MYBBP1A interactions | 7.71e-04 | 463 | 48 | 6 | int:MYBBP1A | |
| Interaction | CBX3 interactions | 7.90e-04 | 646 | 48 | 7 | int:CBX3 | |
| Interaction | NUP133 interactions | 7.94e-04 | 175 | 48 | 4 | int:NUP133 | |
| Interaction | MKI67 interactions | 8.05e-04 | 648 | 48 | 7 | int:MKI67 | |
| Interaction | RPS8 interactions | 8.12e-04 | 649 | 48 | 7 | int:RPS8 | |
| Interaction | NOP58 interactions | 8.19e-04 | 309 | 48 | 5 | int:NOP58 | |
| Interaction | PANK4 interactions | 8.20e-04 | 77 | 48 | 3 | int:PANK4 | |
| Interaction | TBL3 interactions | 8.45e-04 | 178 | 48 | 4 | int:TBL3 | |
| Interaction | S100B interactions | 8.63e-04 | 179 | 48 | 4 | int:S100B | |
| Interaction | H1-4 interactions | 8.65e-04 | 656 | 48 | 7 | int:H1-4 | |
| Interaction | HADHB interactions | 8.91e-04 | 476 | 48 | 6 | int:HADHB | |
| GeneFamily | PHD finger proteins | 3.34e-05 | 90 | 37 | 4 | 88 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.66e-04 | 12 | 37 | 2 | 1305 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.09e-03 | 24 | 37 | 2 | 654 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.09e-03 | 24 | 37 | 2 | 485 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.28e-03 | 26 | 37 | 2 | 253 | |
| GeneFamily | Ankyrin repeat domain containing | 1.32e-02 | 242 | 37 | 3 | 403 | |
| Coexpression | GARY_CD5_TARGETS_UP | 2.32e-05 | 473 | 48 | 7 | M17693 | |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_UP | 2.65e-05 | 192 | 48 | 5 | M6732 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 2.14e-06 | 195 | 48 | 5 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-06 | 198 | 48 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.65e-05 | 160 | 48 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 163 | 48 | 4 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-05 | 163 | 48 | 4 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-05 | 170 | 48 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-05 | 171 | 48 | 4 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-05 | 173 | 48 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-05 | 174 | 48 | 4 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 175 | 48 | 4 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 4.11e-05 | 179 | 48 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.48e-05 | 183 | 48 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.48e-05 | 183 | 48 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 187 | 48 | 4 | c2940aec30b3c2c113f6a65126dc6f1969cf301e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 192 | 48 | 4 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 193 | 48 | 4 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 194 | 48 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.62e-05 | 194 | 48 | 4 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 196 | 48 | 4 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 196 | 48 | 4 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 5.85e-05 | 196 | 48 | 4 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.97e-05 | 197 | 48 | 4 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.08e-05 | 198 | 48 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | (220)_CD8+_Cytotoxic_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.08e-05 | 198 | 48 | 4 | 2af389b8ea5767ba56fe64d719afe5be3f9a43ec | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell-(220)_CD8+_Cytotoxic_T_cell|(22)_CD8+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 6.08e-05 | 198 | 48 | 4 | 1bb60688ff0e42471c8b646652fe95b9b28c41a3 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 6.20e-05 | 199 | 48 | 4 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.20e-05 | 199 | 48 | 4 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.20e-05 | 199 | 48 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T|ICU-NoSEP / Disease, condition lineage and cell class | 6.20e-05 | 199 | 48 | 4 | 7fb211f803a8b3a2cfa9455386abea08131c6b52 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.33e-05 | 200 | 48 | 4 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.33e-05 | 200 | 48 | 4 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 112 | 48 | 3 | 32c6ab8e9b71c6c3df7e3e119b88e6ad1b895d50 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.80e-04 | 142 | 48 | 3 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 5.20e-04 | 146 | 48 | 3 | 035393166f3ad5ab95602a8ae11b7d0ee4b1d691 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 5.41e-04 | 148 | 48 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 150 | 48 | 3 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-04 | 152 | 48 | 3 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.85e-04 | 152 | 48 | 3 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-04 | 152 | 48 | 3 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.96e-04 | 153 | 48 | 3 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.96e-04 | 153 | 48 | 3 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.96e-04 | 153 | 48 | 3 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 6.31e-04 | 156 | 48 | 3 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-04 | 156 | 48 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.43e-04 | 157 | 48 | 3 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-04 | 158 | 48 | 3 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.54e-04 | 158 | 48 | 3 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.67e-04 | 159 | 48 | 3 | a710551512aa0b7a281a81bea651a43c9f3b3539 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.67e-04 | 159 | 48 | 3 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-04 | 160 | 48 | 3 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.79e-04 | 160 | 48 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-04 | 160 | 48 | 3 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.91e-04 | 161 | 48 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-04 | 161 | 48 | 3 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 162 | 48 | 3 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.16e-04 | 163 | 48 | 3 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.29e-04 | 164 | 48 | 3 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-04 | 165 | 48 | 3 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-04 | 165 | 48 | 3 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.42e-04 | 165 | 48 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.82e-04 | 168 | 48 | 3 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-04 | 169 | 48 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.09e-04 | 170 | 48 | 3 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.23e-04 | 171 | 48 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.23e-04 | 171 | 48 | 3 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.23e-04 | 171 | 48 | 3 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 8.23e-04 | 171 | 48 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-04 | 172 | 48 | 3 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.37e-04 | 172 | 48 | 3 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-04 | 172 | 48 | 3 | 1171e754fd503a0c1152162fcc12a115088a08c7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-04 | 172 | 48 | 3 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.37e-04 | 172 | 48 | 3 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 8.51e-04 | 173 | 48 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.51e-04 | 173 | 48 | 3 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-04 | 173 | 48 | 3 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.65e-04 | 174 | 48 | 3 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-04 | 174 | 48 | 3 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.65e-04 | 174 | 48 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.80e-04 | 175 | 48 | 3 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.80e-04 | 175 | 48 | 3 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.94e-04 | 176 | 48 | 3 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.09e-04 | 177 | 48 | 3 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-04 | 177 | 48 | 3 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.24e-04 | 178 | 48 | 3 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-04 | 178 | 48 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.24e-04 | 178 | 48 | 3 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-04 | 179 | 48 | 3 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.39e-04 | 179 | 48 | 3 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.39e-04 | 179 | 48 | 3 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.39e-04 | 179 | 48 | 3 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 9.39e-04 | 179 | 48 | 3 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 9.39e-04 | 179 | 48 | 3 | 3dc929a10381b7d86650c6cd8f354892fe1d93e7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.54e-04 | 180 | 48 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-04 | 181 | 48 | 3 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 9.70e-04 | 181 | 48 | 3 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.70e-04 | 181 | 48 | 3 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-04 | 181 | 48 | 3 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.70e-04 | 181 | 48 | 3 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| Drug | L-Arg-L-phe | 1.30e-05 | 3 | 48 | 2 | CID000150964 | |
| Drug | NSC-686960 | 2.60e-05 | 4 | 48 | 2 | CID000192816 | |
| Drug | Nilvadipine | 4.33e-05 | 5 | 48 | 2 | DB06712 | |
| Drug | Nisoldipine | 4.33e-05 | 5 | 48 | 2 | DB00401 | |
| Drug | B 874-67 | 4.33e-05 | 5 | 48 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 4.33e-05 | 5 | 48 | 2 | CID000084253 | |
| Drug | nemadipine-A | 4.33e-05 | 5 | 48 | 2 | CID002856102 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 5.04e-05 | 191 | 48 | 5 | 994_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.42e-05 | 194 | 48 | 5 | 6794_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 6781_DN | |
| Drug | CPU-23 | 6.49e-05 | 6 | 48 | 2 | CID003036051 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.55e-05 | 4 | 48 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | resting heart rate | 1.02e-04 | 149 | 48 | 4 | EFO_0004351 | |
| Disease | Calcium channel blocker use measurement | 4.00e-04 | 213 | 48 | 4 | EFO_0009930 | |
| Disease | cardiovascular disease | 8.63e-04 | 457 | 48 | 5 | EFO_0000319 | |
| Disease | Uterine leiomyoma, breast carcinoma | 1.25e-03 | 32 | 48 | 2 | EFO_0000305, HP_0000131 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.58e-03 | 36 | 48 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | body weights and measures | 1.75e-03 | 38 | 48 | 2 | EFO_0004324 | |
| Disease | sexual dimorphism measurement | 1.96e-03 | 1106 | 48 | 7 | EFO_0021796 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.14e-03 | 335 | 48 | 4 | EFO_0009931 | |
| Disease | Mood Disorders | 2.60e-03 | 168 | 48 | 3 | C0525045 | |
| Disease | Diuretic use measurement | 2.64e-03 | 169 | 48 | 3 | EFO_0009928 | |
| Disease | Schizophrenia | 2.97e-03 | 883 | 48 | 6 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTEKLKEQGKSKRRF | 1806 | Q96QE3 | |
| KIKKRRQGELDGFLK | 101 | P0C875 | |
| KKRKKETKGREVRFG | 456 | Q6UB99 | |
| EDTRLPKRLLKKGKK | 651 | Q8TDI0 | |
| PKRLLKKGKKLRDDK | 656 | Q8TDI0 | |
| DIFKKKKRKGQEDRK | 236 | Q8NDD1 | |
| FKDSRLKRKGLVKKV | 301 | Q99933 | |
| DADEIKRLGKRFKKL | 16 | P63098 | |
| ELLSRKKREKKKKTG | 181 | Q96KC8 | |
| KKKGLFSRRKEDPAL | 1236 | O14578 | |
| EARKKALKLGAKKVF | 46 | P00966 | |
| KGKGQIEKRKLREKR | 146 | Q96IZ0 | |
| ALLKKGKFGKRESRK | 386 | Q6ZRI8 | |
| LLAKKKGKSLAGKRL | 451 | P49758 | |
| KEAKDAKGSRRKKSL | 2121 | Q04721 | |
| KLKDKDFGKQALRKE | 381 | Q9UQ53 | |
| KKSKRAIRLFKEGKE | 116 | Q13191 | |
| KRGKKKKRGRATDSF | 61 | Q9HBH9 | |
| KKRSRGKAKKLKFGL | 96 | Q4G0M1 | |
| DGEKRKKRRGKKKVS | 401 | Q9Y496 | |
| RKKRREKKAAELAKG | 111 | P17568 | |
| GKRGRKLKSKLEKTK | 816 | Q9ULT8 | |
| LKPGKEDKLFRKKRR | 856 | Q8NHM5 | |
| FRKFKKRKEQGLVGK | 1676 | Q13936 | |
| SGLATLKKKFIKRRK | 61 | Q9P203 | |
| RLKKKGGEKMALLEK | 226 | Q8WTQ7 | |
| EEGRPGKKLKKVKLR | 681 | Q14839 | |
| FRKFKKRKEQGLVGK | 1616 | Q01668 | |
| RKGKFRKSRLKLKDG | 501 | P80192 | |
| KKKGIKSSIGRLFGK | 826 | O75334 | |
| KSSIGRLFGKKEKAR | 831 | O75334 | |
| KLKEELGKLKGKSER | 106 | Q96CV9 | |
| LKKKGKDLINFSKRR | 946 | Q07890 | |
| RKGKFKRSRLKLKDG | 496 | Q5TCX8 | |
| DVDKIEKKGKGKKRR | 3676 | Q6P3W6 | |
| AKKEQKKGKGLRFKR | 46 | Q6DKI1 | |
| KKGKGLRFKRLESFL | 51 | Q6DKI1 | |
| DGIELGKSSKREKKK | 531 | Q8NE18 | |
| KRFKLEEKVKKGGSG | 211 | P55318 | |
| KRLDEKFGAPDKRLK | 491 | P48634 | |
| KAELKLEKKSGRKPR | 16 | Q96M53 | |
| KKKLAFLSGGKDRRS | 11 | Q86VW0 | |
| TAGKAKVKSKRRLEK | 161 | Q9HAW4 | |
| GKERKRFKLSKGELK | 21 | Q8WXG8 | |
| KKALEELATKRFKGK | 76 | Q9BW30 | |
| RKKLILAKKFSKDLG | 76 | P86452 | |
| RKFEEKYGGKKRRKD | 106 | Q9NPG3 | |
| LKPKELFKKAERKGK | 531 | Q9UPP1 | |
| KKKGEFPGEKSKRLR | 1231 | Q12789 | |
| EDGKKVFLLAGRKRK | 291 | P50607 | |
| FDRGKEKKIKKFKRE | 1076 | Q9P275 | |
| INGDKKAKKGRRKLK | 731 | Q9NR99 |